Intuitive Surgical Q4 revenue $1.93B (+17% YoY); 2024 procedure growth guidance 13-16%

INTUITIVE SURGICAL INC

2023-FY EPS reported $5.03 revenue$7,124,100,000

Q4 2023 revenue $1.93B (+17% YoY); full-year 2023 revenue $7.12B (+14% YoY).
Worldwide da Vinci procedures grew 21% in Q4 and 22% in full-year 2023.
Placed 415 da Vinci systems in Q4 (+12% YoY); 1,370 systems in 2023 (+8% YoY).
Instruments & accessories revenue up 22% in Q4 and full year to $1.14B and $4.28B.
Expects 2024 worldwide procedure growth of 13% to 16%.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

INTUITIVE SURGICAL INC reported the fourth quarter and full year 2023 results: revenue approximately $1.93 billion. Guidance reaffirmed.

Period: the fourth quarter and full year 2023
Revenue: approximately $1.93 billion
Guidance: reaffirmed
Result: preliminary results

Exact text from the filing

The Company placed 1,370 da Vinci surgical systems in 2023, an increase of 8% compared with 1,264 systems in 2022. • Preliminary fourth quarter 2023 revenue of approximately $1.93 billion increased 17% compared with $1.66 billion in the fourth quarter of 2022. Preliminary 2023 revenue of approximately $7.12 billion increased 14% compared with $6.22 billion in

View on SEC.gov

20 earnings releases filed in the last 30 days. Browse all earnings releases →

INTUITIVE SURGICAL INC filing history →

Source: SEC EDGAR

accession 0001035267-24-000006

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.